<table className="table">
  <caption><p>
    Recommendations for Measurement of Bone Mineral Density</p>
  </caption>
  <thead>
    <tr>
      <th rowSpan="1" colSpan="1"><p>
        Bone Mineral Density Testing<sup>
        a,b</sup></p>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr className="group_1-1 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Women aged ≥65 years</p><p>
        Men: Guidelines for routine screening vary by organization<sup>
        c</sup></p>
      </td>
    </tr>
    <tr className="group_1-2 row-even">
      <td rowSpan="1" colSpan="1"><p>
        Postmenopausal women aged &lt;65 years and men aged 50-69 years, based on risk-factor profile<sup>
        c</sup></p>
      </td>
    </tr>
    <tr className="group_1-3 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Fragility fracture, to determine degree of disease severity</p>
      </td>
    </tr>
    <tr className="group_1-4 row-even">
      <td rowSpan="1" colSpan="1"><p>
        Radiographic findings suggestive of osteoporosis or vertebral deformity</p>
      </td>
    </tr>
    <tr className="group_1-5 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        As soon as possible after initiation of long-term glucocorticoid therapy (≥2.5 mg/d for &gt;3 months)</p>
      </td>
    </tr>
    <tr className="group_1-6 row-even">
      <td rowSpan="1" colSpan="1"><p>
        Condition associated with osteoporosis</p>
      </td>
    </tr>
    <tr className="group_1-7 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Primary hyperparathyroidism<sup>
        d</sup></p>
      </td>
    </tr>
  </tbody>
</table>